In think they are right, move clinical trials will move overseas...BD
The change, which goes into effect in Octoer, is likely to push more clinical trials abroad, where an estimated 35 percent of all trials submitted to the FDA in new drug applications now take place, according to ISW. Unlike trials conducted in the US, drugmakers don’t have to submit an investigational new drug application (IND) to the FDA before beginning research in foreign countries.
0 comments :
Post a Comment